Appointment of New South African-based Chief Financial Officer and Finance Director to the Board
Neo Energy Metals Prepares to Lift Trading Suspension as Major Asset Acquisitions Advance
Neo Energy Metals plc has announced that the temporary suspension of its shares on the London Stock Exchange is expected to be lifted shortly, following the completion and publication of its
Princes Group Floats on London Stock Exchange with £1.16bn Valuation
Princes Group, the 150-year-old food and drink manufacturer best known for Princes Tuna and Branston Beans, made its stock market debut in London this morning with a market capitalisation of
Q&A session with NEO Energy Metals CEO and Chairman
Neo Energy Metals LIVE Q&A: Beatrix 4 Shaft, Funding, Permits and Timelines
Helix Exploration Confirms Geological Hydrogen Potential at Rudyard Project
Helix Exploration PLC has reported breakthrough results from its Rudyard Project, confirming significant potential for geological hydrogen generation.
Neo Energy Metals (LON: NEO, A2X: NEO) Update on Investor Presentation
Neo Energy, the near-term, low-cost uranium developer, wishes to advise the public that the Investor Presentation previously announced on 3 September 2025 has been rescheduled to Wednesday, 22 October 2025 at
Genflow Biosciences Shares Jump 25% on Positive Dog Aging Gene Therapy Results
Update on Animal Health Program
Genflow Biosciences (LON: GENF) Shares Jump 100% After Alternative Share Placement
Genflow Biosciences Raises £440,000 Through Alternative Share Placement.
Neo Energy to publish annual results within two weeks, plans to lift trading suspension
Neo Energy Metals announced that it expects to release its annual results for the year ended September 30, 2024, within the next two weeks, with interim results for the six
Neo Energy Metals (LON: NEO, A2X: NEO) Update on Audit Progress and Trading Resumption
Neo Energy, the near-term, low-cost uranium developer, provides a comprehensive update on the status of its annual report and accounts for the year ended 30 September 2024 (the “Accounts”), regulatory timelines,
Genflow Biosciences (LON: GENF) Files Patent Examination Request in China for SIRT6 Variants in NASH
Genflow Biosciences PLC (LON: GENF) has submitted a formal request for examination of its patent application in China relating to proprietary SIRT6 variants designed for the treatment of Non-Alcoholic Steatohepatitis
Neo Energy – Annual Report and Accounts, Audit Progress and Trading Resumption
Update on Annual Report and Accounts, Audit Progress and Trading Resumption